Does the presence of a POLE mutation in endometrial cancer guide your recommendations regarding adjuvant radiation?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on
It’s part of PORTEC 4 study to randomize patients to adjuvant RT based on molecular subtype. They are exploring if observation is suitable option for POLE type
Outside of a trial we still decide based on stage and grade for adjuvant treatment and not on molecular subtype.
Join for free or sign in to see the full answer